Enveric Biosciences Stock News

Enveric Biosciences (NASDAQ:ENVB) announced that Bob Dagher will be joining the company as its chief medical officer. The psychedelic company said that Dagher brings over 20 years of experience worki

The usage of psychedelics like psilocybin, LSD, ketamine, and others are becoming more mainstream, especially with the initial steps to legalization getting moving across a number of states in the U.S

Enveric Biosciences Inc. (NASDAQ:ENVB) has a beta value of 1.59 and has seen 1.25 million shares traded in the last trading session. The company, currently valued at $43.28M, closed the last trade at $1.38 per share which meant it lost -$0.07 on the day or -4.83% during that session. The ENVB stock price is -989.86% An In-Depth Look At Enveric Biosciences Inc. (ENVB) Read More »

NAPLES, Fla., Nov. 29, 2021 /PRNewswire/ - Enveric Biosciences  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and onc

Enveric Biosciences, Inc. (NASDAQ:ENVB) saw a significant growth in short interest in the month of October. As of October 29th, there was short interest totalling 1,960,000 shares, a growth of 16.0% from the October 14th total of 1,690,000 shares. Approximately 13.8% of the shares of the company are sold short. Based on an average daily []

In the last trading session, 1.21 million shares of the Enveric Biosciences Inc. (NASDAQ:ENVB) were traded, and its beta was 1.59. Most recently the companys share price was $1.49, and it changed around -$0.13 or -8.02% from the last close, which brings the market valuation of the company to $46.73M. ENVB currently trades at a Enveric Biosciences Inc. (NASDAQ: ENVB): The Stock To Bet On For Economic Progress In The Months Ahead Read More »

Enveric Biosciences Inc. (NASDAQ:ENVB)s traded shares stood at 1.2 million during the last session, with the companys beta value hitting 1.59. At the close of trading, the stocks price was $1.62, to imply a decrease of -5.26% or -$0.09 in intraday trading. The ENVB shares 52-week high remains $15.04, putting it -828.4% down since that Enveric Biosciences Inc. (NASDAQ: ENVB) Stocks Fall -61.97% YTD; What Next For It? Read More »

Enveric Biosciences (NASDAQ: ENVB) announced data from a preclinical rodent model evaluating EV102, the company's cannabidiol (CBD) based product in development for the topical treatment of radiode

Enveric Biosciences Inc has announced that EV102, its cannabidiol-based product (CBD) in development for the topical prescription treatment of radiodermatitis, has demonstrated a significant and mean

Nabriva Therapeutics (NASDAQ:NBRV) and Enveric Biosciences (NASDAQ:ENVB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations. Profitability This table compares Nabriva Therapeutics and Enveric Biosciences’ net margins, return on equity and […]

Looking for penny stocks to watch right now? Check these three out The post Hot Penny Stocks to Buy That You Should Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Informat

Are these 10 penny stocks on your watch list this week? The post Best Penny Stocks To Buy This Week?

NAPLES, Fla., Oct. 7, 2021 /PRNewswire/ --  Enveric Biosciences  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and on

Enveric Biosciences Inc has taken a step further in its bid to develop psychedelic drug candidates, by using a machine-learning platform to identify molecules which could be advanced into pre-clinical

The stock price of Enveric Biosciences Inc (NASDAQ: ENVB) increased by over 6% this morning. This is why it happened.